Your browser doesn't support javascript.
loading
First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study.
Pernas, Sonia; Villagrasa, Patricia; Vivancos, Ana; Scaltriti, Maurizio; Rodón, Jordi; Burgués, Octavio; Nuciforo, Paolo; Canes, Jordi; Paré, Laia; Dueñas, Marta; Vidal, Maria; Cejalvo, Juan Miguel; Perelló, Antonia; Llommbard-Cussac, Antonio; Dorca, Joan; Montaño, Alvaro; Pascual, Tomás; Oliveira, Mafalda; Ribas, Gloria; Rapado, Inmaculada; Prat, Aleix; Ciruelos, Eva.
Affiliation
  • Pernas S; Catalan Institute of Oncology (ICO)- Institut d'Investigació Biomédica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Villagrasa P; SOLTI Breast Cancer Research Group, Barcelona, Spain.
  • Vivancos A; SOLTI Breast Cancer Research Group, Barcelona, Spain.
  • Scaltriti M; Cancer Genomics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Rodón J; Memorial Sloan Kettering Cancer Center, Memorial Hospital, New York, NY, United States.
  • Burgués O; Oncology Department, Monroe Dunaway (MD) Anderson Cancer Center, Houston, TX, United States.
  • Nuciforo P; Oncology Department, Vall d'Hebron University Hospital/Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Canes J; Pathology Department, Hospital Clínico Universitario Valencia, Valencia, Spain.
  • Paré L; Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Dueñas M; SOLTI Breast Cancer Research Group, Barcelona, Spain.
  • Vidal M; SOLTI Breast Cancer Research Group, Barcelona, Spain.
  • Cejalvo JM; Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain.
  • Perelló A; Institute of Biomedical Research, University Hospital "12 de Octubre", Madrid, Spain.
  • Llommbard-Cussac A; SOLTI Breast Cancer Research Group, Barcelona, Spain.
  • Dorca J; Oncology Department, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Montaño A; Translational Genomics and Targeted Therapeutics in Solid Tumors, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Pascual T; Pathology Department, Hospital Clínico Universitario Valencia, Valencia, Spain.
  • Oliveira M; Breast Cancer Biology, Instituto de Investigación Sanitaria (INCLIVA) Biomedical Research Institute, Valencia, Spain.
  • Ribas G; Center for Biomedical Network Research on Cancer (CIBERONC), Valencia, Spain.
  • Rapado I; Oncology Department, Hospital Universitari Son Espases, Palma de Mallorca, Spain.
  • Prat A; Oncology Department, Fundación para el Fomento de la Investigación Sanitaria y Biomédica (FISABIO) - Hospital Arnau de Vilanova, Valencia, Spain.
  • Ciruelos E; Oncology Department, Catalan Institute of Oncology (ICO), Girona, Spain.
Front Oncol ; 11: 744112, 2021.
Article in En | MEDLINE | ID: mdl-34804931
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Screening_studies Language: En Journal: Front Oncol Year: 2021 Document type: Article Affiliation country: España Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Screening_studies Language: En Journal: Front Oncol Year: 2021 Document type: Article Affiliation country: España Country of publication: Suiza